Fuan Pharmaceutical: The registration of injectable adenosine dimethylsulfonate has been completed
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Fuan Pharmaceutical announced that its wholly-owned subsidiary Fuan Pharmaceutical Group Yantai Zhichu Pharmaceutical Co., Ltd. (referred to as "Zhichu Pharmaceutical") recently received a drug registration certificate issued by the National Medical Products Administration, for the drug named Injection Ademetionine. Injection Ademetionine is suitable for pre-cirrhosis and intrahepatic cholestasis caused by cirrhosis; it is also suitable for intrahepatic cholestasis during pregnancy
According to the Zhitong Finance APP, Fuan Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary Fuan Pharmaceutical Group Yantai Zhichu Pharmaceutical Co., Ltd. (referred to as "Zhichu Pharmaceutical") recently received a drug registration certificate issued by the National Medical Products Administration. The drug name is Adenosine Dimethyl Sulfate Injection. Adenosine Dimethyl Sulfate Injection is suitable for pre-cirrhosis and intrahepatic cholestasis caused by cirrhosis; it is also suitable for intrahepatic cholestasis during pregnancy